{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:23:25Z","timestamp":1740108205889,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00134-023-07300-8","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:02:58Z","timestamp":1704794578000},"page":"287-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune-mediated thrombotic thrombocytopenic purpura: don\u2019t miss the boat"],"prefix":"10.1007","volume":"50","author":[{"given":"Adrien","family":"Picod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-1508","authenticated-orcid":false,"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"7300_CR1","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1055\/a-1378-3804","volume":"121","author":"E Mariotte","year":"2021","unstructured":"Mariotte E, Zafrani L, Fadlallah J et al (2021) Performance of diagnostic scores in thrombotic microangiopathy patients in the intensive care unit: a monocentric study. Thromb Haemost 121:1427\u20131434. https:\/\/doi.org\/10.1055\/a-1378-3804","journal-title":"Thromb Haemost"},{"key":"7300_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ajh.24665","volume":"92","author":"M Grall","year":"2017","unstructured":"Grall M, Azoulay E, Galicier L et al (2017) Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre. Am J Hematol 92:381\u2013387. https:\/\/doi.org\/10.1002\/ajh.24665","journal-title":"Am J Hematol"},{"key":"7300_CR3","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/s00134-019-05736-5","volume":"45","author":"E Azoulay","year":"2019","unstructured":"Azoulay E, Bauer PR, Mariotte E et al (2019) Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 45:1518\u20131539. https:\/\/doi.org\/10.1007\/s00134-019-05736-5","journal-title":"Intensive Care Med"},{"key":"7300_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.kint.2018.02.029","volume":"94","author":"F Schaefer","year":"2018","unstructured":"Schaefer F, Ardissino G, Ariceta G et al (2018) Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. Kidney Int 94:408\u2013418. https:\/\/doi.org\/10.1016\/j.kint.2018.02.029","journal-title":"Kidney Int"},{"key":"7300_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1634\/theoncologist.2009-0067","volume":"14","author":"L Oberic","year":"2009","unstructured":"Oberic L, Buffet M, Schwarzinger M et al (2009) Cancer awareness in atypical thrombotic microangiopathies. Oncologist 14:769\u2013779. https:\/\/doi.org\/10.1634\/theoncologist.2009-0067","journal-title":"Oncologist"},{"key":"7300_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","volume":"77","author":"RA Asherson","year":"1998","unstructured":"Asherson RA, Cervera R, Piette JC et al (1998) Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77:195\u2013207. https:\/\/doi.org\/10.1097\/00005792-199805000-00005","journal-title":"Medicine (Baltimore)"},{"key":"7300_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","volume":"51","author":"L Guillevin","year":"2012","unstructured":"Guillevin L, B\u00e9rezn\u00e9 A, Seror R et al (2012) Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. Rheumatol Oxf Engl 51:460\u2013467. https:\/\/doi.org\/10.1093\/rheumatology\/ker271","journal-title":"Rheumatol Oxf Engl"},{"key":"7300_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010208","volume":"5","author":"P Coppo","year":"2010","unstructured":"Coppo P, Schwarzinger M, Buffet M et al (2010) Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS ONE 5:e10208. https:\/\/doi.org\/10.1371\/journal.pone.0010208","journal-title":"PLoS ONE"},{"key":"7300_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1182\/blood.2020008021","volume":"137","author":"P Coppo","year":"2021","unstructured":"Coppo P, Bubenheim M, Azoulay E et al (2021) A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP. Blood 137:733\u2013742. https:\/\/doi.org\/10.1182\/blood.2020008021","journal-title":"Blood"},{"key":"7300_CR10","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.1002\/ajh.23997","volume":"90","author":"Y Benhamou","year":"2015","unstructured":"Benhamou Y, Baudel J-L, Wynckel A et al (2015) Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center: platelet transfusion in thrombotic thrombocytopenic purpura. Am J Hematol 90:E127\u2013E129. https:\/\/doi.org\/10.1002\/ajh.23997","journal-title":"Am J Hematol"},{"key":"7300_CR11","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","volume":"125","author":"R Goel","year":"2015","unstructured":"Goel R, Ness PM, Takemoto CM et al (2015) Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood 125:1470\u20131476. https:\/\/doi.org\/10.1182\/blood-2014-10-605493","journal-title":"Blood"},{"key":"7300_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood.2020009150","volume":"137","author":"A Cuker","year":"2021","unstructured":"Cuker A, Cataland SR, Coppo P et al (2021) Redefining outcomes in immune TTP: an international working group consensus report. Blood 137:1855\u20131861. https:\/\/doi.org\/10.1182\/blood.2020009150","journal-title":"Blood"},{"key":"7300_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.6004\/jadpro.2021.12.2.8","volume":"12","author":"KV Katsivalis","year":"2021","unstructured":"Katsivalis KV, Thomas J (2021) Caplacizumab for acute thrombotic thrombocytopenic purpura. J Adv Pract Oncol 12:211\u2013215. https:\/\/doi.org\/10.6004\/jadpro.2021.12.2.8","journal-title":"J Adv Pract Oncol"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-023-07300-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T21:19:50Z","timestamp":1709587190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-023-07300-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["7300"],"URL":"https:\/\/doi.org\/10.1007\/s00134-023-07300-8","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"type":"print","value":"0342-4642"},{"type":"electronic","value":"1432-1238"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EA has received fees for lecture from Alexion, Sanofi and Pfizer. He has also received a research grant from Alexion. The remaining authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}